ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, when we highly expressed TSPAN32 with BCR-ABL in a CML mouse model, we found that TSPAN32 significantly prevented CML progression (Supplementary Fig. 1).